S-Gal®, a novel1H MRI reporter for β-galactosidase

Magnetic Resonance in Medicine

Volumn 64, Issue 1, 2010, Pages 65-71

  Cui, Weina ^a   Liu, Li ^a   Kodibagkar, Vikram D ^a   Mason, Ralph P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ferric ammonium citrate; lacZ; MCF7 breast tumor; Reporter gene; S Gal ; galactosidase

Indexed keywords

DIRECT INJECTION; GENES; MAMMALS; TUMORS;

BREAST TUMOR; FERRIC AMMONIUM CITRATE; GALACTOSIDASES; LACZ; REPORTER GENE;

ENZYME ACTIVITY;

3,4 CYCLOHEXENOESCULETIN BETA DEXTRO GALACTOPYRANOSIDE; BETA GALACTOSIDASE; FERRIC AMMONIUM CITRATE; REAGENT; S GAL; UNCLASSIFIED DRUG; CONTRAST MEDIUM; CYCLOHEXENOESCULETIN BETA GALACTOSIDE; CYCLOHEXENOESCULETIN-BETA-GALACTOSIDE; GALACTOSIDE; UMBELLIFERONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CONTRAST ENHANCEMENT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REPORTER GENE; ANIMAL; BREAST TUMOR; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; GALACTOSIDES; GENES, REPORTER; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR STRUCTURE; UMBELLIFERONES;

EID: 77953929320     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22400     Document Type: Article

References (32)

1. Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R. In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 2004;64:1579-1583.
2. Wehrman TS, von Degenfeld G, Krutzik P, Nolan GP, Blau HM. Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence. Nat Methods 2006;3:295-301.
3. Liu L, Su Y, Gondim A, Mason RP.Chemiluminescent imaging (CLI): seeing enzyme activity in a new light. 100th Annual Meeting of the AACR American Association for Cancer Research, Denver, CO, 2009. p 4464.
4. Li L, Zemp RJ, Lungu G, Stoica G, Wang LHV. Photoacoustic imaging of lacZ gene expression in vivo. J Biomed Optics 2007;12:020504.
5. Van Dort ME, Lee KC, Hamilton CA, Rehemtulla A, Ross BD. Radiosynthesis and evaluation of 5-[I-125]iodoindol-3-yl-beta-D-galactopyranoside as a beta-galactosidase imaging radioligand. Mol Imaging 2008;7:187-197.
6. Lee KH, Byun SS, Choi JH, Paik JY, Choe YS, Kim BT. Targeting of lacZ reporter gene expression with radioiodine-labelled phenylethyl-beta-d- thiogalactopyranoside. Eur J Nucl Med Mol Imaging 2004;31:433-438. (Pubitemid 38314089)
7. Celen S, Deroose C, de Groot T, Chitneni SK, Gijsbers R, Debyser Z, Mortelmans L, Verbruggen A, Bormans G. Synthesis and evaluation of F-18- and C-11-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography. Bioconj Chem 2008;19:441-449.
8. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000;18:321-325.
9. Cui W, Otten P, Li Y, Koeneman K, Yu J, Mason RP. A novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-β-D-galactopyranoside as a prototype reporter molecule for β-galactosidase. Magn Reson Med 2004;51:616-620. (Pubitemid 38298678)
10. Yu JX, Otten P, Ma Z, Cui W, Liu L, Mason RP. A novel NMR platform for detecting gene transfection: synthesis and evaluation of fluorinated phenyl β-D-galactosides with potential application for assessing LacZ gene expression. Bioconj Chem 2004;15:1334-1341. (Pubitemid 39552023)
11. 19F NMR of a fluorinated vitamin B6 conjugate. Med Chem 2005;1:255-262.
12. Liu L, Kodibagkar VD, Yu J-X, Mason RP. 19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl β-D-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse. FASEB J 2007;21:2014-2019. (Pubitemid 47026437)
13. 19F NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo. NMR Biomed 2008;21:704-712.
14. 19F chemical shift imaging of LacZ gene-reporter molecule 2-fluoro-4-nitrophenol-β-D-galactopyranoside. Magn Reson Imaging 2006;24:959-962.
15. 19F NMR of trifluoromethylated aryl beta-D-galactopyranosides. Bioorg Med Chem 2006;14:326-333.
16. Heuermann K, Cosgrove J. S-Gal: an autoclavable dye for color selection of cloned DNA inserts. Biotechniques 2001;30:1142-1147.
17. Bradford MM. A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
18. 1H MRI reporter for β-galactosidase. Proc 12th International Society for Magnetic Resonance in Medicine, Kyoto, Japan, 2004. p 1712.
19. 2O)] for tracing gene expression. Bioconjug Chem 2007;18:1716-1727.
20. Chauvin T, Durand P, Bernier M, Meudal H, Doan BT, Noury F, Badet B, Beloeil JC, Toth E. Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Angew Chem Int Ed 2008;47:4370-4372.
21. 3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Chem Eur J 2008;14:987-995.
22. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452:580-589.
23. Contag CH, Ross BD. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 2002;16:378-387.
24. Yaghoubi SS, Gambhir SS. PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [F-18] FHBG. Nat Protoc 2006;1:3069-3075.
25. Barton KN, Tyson D, Stricker H, Lew YS, Heisey G, Koul S, de la Zerda A, Yin FF, Yan H, Nagaraja TN, Randall KA, Jin GK, Fenstermacher JD, Jhiang S, Kim JH, Freytag SO, Brown SL. GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. J Am Soc Gene Ther 2003;8:508-518.
26. Moore A, Josephson L, Bhorade RM, Basilion JP, Weissleder R. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001;221:244-250. (Pubitemid 32880396)
27. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia (New York) 2005;7:109-117. (Pubitemid 40315988)
28. Zurkiya O, Chan AWS, Hu XP. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 2008;59:1225-1231.
29. Gilad AA, Winnard PT, van Zijl PCM, Bulte JWM. Developing MR reporter genes: promises and pitfalls. NMR Biomed 2007;20:275-290.
30. Koretsky AP, Brosnan MJ, Chen LH, Chen JD, Vandyke T. NMR detection of creatine-kinase expressed in liver of transgenic micedetermination of free ADP levels. Proc Natl Acad Sci U|S|A 1990;87:3112-3116.
31. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawrence TS, Blasberg RG, Tjuvajev JG, Ross BD. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U|S|A 1999;96:9821-9826.
32. Bengtsson NE, Walter GA, Scott EW.A gene reporter system for detection of cellular LacZ expression by magnetic resonance imaging. Proc. 16th Intl. Soc. Mag. Reson. Med., Toronto, 2008. p 1660.